Swiss Secondary Prevention and Rehabilitation Registry
ConditionCardiovascular Diseases (CVD)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Basel, Switzerland
About this trial
The SwissPR study is to continuously monitor patient characteristics and short- and long-term benchmark quality measures and outcomes of patients participating in a 12-week ambulatory CR program.
Eligibility criteria
Qualifiers
Participation in an ambulatory CR program (all age groups)
Written informed consent
Disqualifiers
Inability to follow an ambulatory CR program more than 3 weeks
Not willing to give informed consent
Inability to understand the informed consent due to language comprehension
Lack of discernment
Trial design
Treatments tested in this trial
- Data collection at Baseline, 3 months after baseline (BL), 1-year follow-up, Telephone follow-up and questionnaire 3 years and 5 years after BL
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov